NEUROTERA project funded

BSIM Therapeutics has secured support for its NEUROTERA project by COMPETE 2020 of PT2020, through the European Regional Development Fund.

This project aims at exploiting our potent TTR amyloid inhibitors, by targeting selected drug candidates to the eye and the brain, for the treatment of the clinical manifestations linked with those organs.